Abstract:Rationale: Post-translational modifications have emerged as vital players in alterations to tumor metabolism, including amino acid metabolic reprogramming. Jumonji domain-containing protein 2B (JMJD2B) enhances colorectal cancer (CRC) cell survival upon glucose deficiency. In the present study, we hypothesized that JMJD2B affects tumor cell amino acid metabolism in CRC and consequently promotes survival of CRC cells upon glucose deprivation.Methods: Non-target metabolic profiling was used to evaluate the roles of JMJD2B in CRC cell metabolism under glucose starvation. The roles of amino acid alterations induced by JMJD2B on CRC cell survival were determined by cell viability, immunoblotting, and clonogenic assays, and flow cytometry. The underlying mechanisms by which JMJD2B affected CRC cell metabolism were assessed using immunofluorescence staining, chromatin immunoprecipitation assays, electron microscopy in CRC cell lines, and using xenograft models. The correlation between JMJD2B and LC3B expression in human CRC specimens was assessed using immunohistochemistry.Results: Profound metabolic reprogramming was detected in JMJD2B knockdown CRC cells under glucose deficiency, especially those involving amino acid metabolites. Silencing of JMJD2B reduced the levels of certain amino acids that were induced by glucose deficiency. Among these amino acids, asparagine (Asn), phenylalanine (Phe), and histidine (His) promoted CRC cell survival under glucose starvation when JMJD2B was knocked down. Mechanistically, downregulation of JMJD2B inhibited autophagy in CRC cells through epigenetic regulation of microtubule associated protein 1 light chain 3 beta (LC3B), and subsequently decreased intracellular amino acid (Asn, Phe, His) levels under glucose deprivation, thus suppressing the survival of CRC cells. Using a nude mouse xenograft model, we verified that inhibiting JMJD2B could decrease the levels of amino acids (Asn, Phe, His). In addition, the inhibitory effects of JMJD2B-knockdown on tumor growth and amino acids level were rescued by overexpression of LC3B. Furthermore, we observed that the high expression of LC3B was more likely detected in tissuses with high expression of JMJD2B (P < 0.001) in 60 human CRC tissues.Conclusion: These results indicated that JMJD2B sustained the intracellular amino acids derived from autophagy in CRC cells upon glucose deficiency, partly through epigenetic regulation of LC3B, thus driving the malignancy of CRC.

Silencing of JMJD2B Induces Cell Apoptosis Via Mitochondria-Mediated and Death Receptor-Mediated Pathway Activation in Colorectal Cancer.

Jumonji Domain-Containing Protein 2B Silencing Induces DNA Damage Response Via STAT3 Pathway in Colorectal Cancer.

JMJD5 Interacts with P53 and Negatively Regulates P53 Function in Control of Cell Cycle and Proliferation.

Inhibition of JAK2/STAT3 signalling induces colorectal cancer cell apoptosis via mitochondrial pathway.

JMJD2B-induced amino acid alterations enhance the survival of colorectal cancer cells under glucose-deprivation via autophagy

HIF-1α-induced Histone Demethylase JMJD2B Contributes to the Malignant Phenotype of Colorectal Cancer Cells Via an Epigenetic Mechanism

Bcl-2 Constitutively Suppresses P53-Dependent Apoptosis in Colorectal Cancer Cells.

COPB2 Gene Silencing Inhibits Colorectal Cancer Cell Proliferation and Induces Apoptosis Via the JNK/c-Jun Signaling Pathway

JmjC domain-containing protein 8 (JMJD8) represses Ku70/Ku80 expression via attenuating AKT/NF-κB/COX-2 signaling.

Silencing Of Cxcr7 Gene Represses Growth And Invasion And Induces Apoptosis In Colorectal Cancer Through Erk And Beta-Arrestin Pathways

Jolkinolide B induces apoptosis of colorectal carcinoma through ROS-ER stress-Ca 2+ -mitochondria dependent pathway.

Demethylase JMJD2D induces PD-L1 expression to promote colorectal cancer immune escape by enhancing IFNGR1-STAT3-IRF1 signaling

Inflammation-induced JMJD2D Promotes Colitis Recovery and Colon Tumorigenesis by Activating Hedgehog Signaling

Jolkinolide B induces apoptosis of colorectal carcinoma through ROS-ER stress-Ca2+-mitochondria dependent pathway

Effects of Sirna-Mediated Knockdown of Jumonji Domain Containing 2A on Proliferation, Migration and Invasion of the Human Breast Cancer Cell Line MCF-7.

Effects of RNA Interference-Mediated Gene Silencing of JMJD2A on Human Breast Cancer Cell Line MDA-MB-231 in Vitro

A Polymorphism in JMJD2C Alters the Cleavage by Caspase-3 and the Prognosis of Human Breast Cancer

Silencing of RHEB Inhibits Cell Proliferation and Promotes Apoptosis in Colorectal Cancer Cells Via Inhibition of the Mtor Signaling Pathway

MiR-873-5p Suppresses Cell Proliferation and Epithelial–mesenchymal Transition Via Directly Targeting Jumonji Domain-Containing Protein 8 Through the NF-κB Pathway in Colorectal Cancer

Histone demethylase JMJD1A promotes colorectal cancer growth and metastasis by enhancing Wnt/β-catenin signaling

Silencing of Cadherin-17 Enhances Apoptosis and Inhibits Autophagy in Colorectal Cancer Cells.